- Adults
- General population
- Elderly
- Hospital wide
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
Population: Elderly
Individuals aged 65 years and above
- Adults
- Elderly
- Primary care
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- Adults
- Elderly
- Fragile population
- Immunocompromised host
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Monoclonal antibodies
- AZD3152
- Adults
- General population
- Elderly
- People at high risk of STIs
- Men who have sex with men
- Hospital wide
- Outpatient clinic
- Infectious diseases unit
- Monkeypox virus
- Monkeypox virus infection
- Adults
- General population
- Elderly
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- Adults
- General population
- Elderly
- Hospital wide
- Intensive care unit
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Monkeypox virus
- Monkeypox virus infection
- Pharmacological intervention
- Antivirals
- Tecovirimat
- Adults
- General population
- Elderly
- Hospital wide
- Outpatient clinic
- Intensive care unit
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Molnupiravir
- Adults
- General population
- Elderly
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Remdesivir
- Adults
- General population
- Elderly
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- SARS-CoV-2
- Post-COVID-19